Jade Biosciences Inc. (JBIO) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear

Jade Biosciences Inc.

NASDAQ: JBIO · Real-Time Price · USD
8.86
0.53 (6.36%)
At close: Oct 03, 2025, 3:59 PM
8.35
-5.76%
After-hours: Oct 03, 2025, 05:57 PM EDT

Jade Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023
Period Ending Jun 30, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023
Net Income
-32.13M -5.43M -16.87M -24.77M -23.19M -20.41M -19.56M
Depreciation & Amortization
1K 8K n/a 28K 28K 28K 25K
Stock-Based Compensation
n/a n/a 27K n/a n/a n/a n/a
Other Working Capital
-860K -5.88M 8.04M 193K -4.79M 4.32M 3.51M
Other Non-Cash Items
-8.63M 943.22K -7.54M 3.17M 3.44M 2.31M 2.43M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
4.23M -6.57M 8.34M 1.14M -3.96M 3.27M 1.5M
Operating Cash Flow
-36.53M -11.05M -16.04M -20.43M -23.67M -14.8M -15.61M
Capital Expenditures
-136K n/a n/a n/a n/a -64K -32K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a -4.93M n/a -14.75M -27.79M -47.85M
Sales Maturities Of Investments
-12.85M 13.13M 21M 18M 23.58M 33.5M 34.75M
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
-12.99M 13.13M 16.07M 18M 8.83M 5.65M -13.13M
Debt Repayment
n/a n/a 95M n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
156K n/a -95M n/a n/a n/a n/a
Financial Cash Flow
190.61M 554K 22K 24.38M 471K 463K 20K
Net Cash Flow
176.72M 2.64M 46K 21.95M -14.37M -8.69M -28.72M
Free Cash Flow
-36.67M -11.05M -6.8M -20.43M -23.67M -14.86M -15.64M